The primary and secondary packaging of pharmaceutical products is meticulously connected to their production and constitutes an important part of the value-added procedure. The quality control unit at Paras Printpack is accountable for the regulator of pharmaceutical packaging materials counting their receipt, identification, sampling, testing, and approval or rejection of drug product ampules and closures. The obligation for the tests lies now more and more with the manufacturers of packaging materials. However, as a prerequisite for this, additional QA methods, like vendor qualification, supplier audit and technical agreements, have to be booked.
Packaging can be demarcated as an economical means of providing demonstration, fortification, identification information, suppression, convenience and acquiescence for a product during storage, carriage, display and until the product is consumed. Packaging must provide security against climatic disorders biological, physical and chemical hazards and must be economical. The package must ensure sufficient stability of the product throughout the shelf life.
Numerous important performance characteristics of packaging embrace:
- Ability to endure physical conditions of the explicit sterilization process
- Passable air removal; sterile penetration and contact with the contents; and withdrawal of the sterile.
- Free of toxic materials or dyes; and be low-lining.
- Tolerable barrier to micro-organisms and environmental contaminants
- Durability to resist tears and punctures
- Exclusion of the contents without contamination
- Furthermore, packaging systems should be easy to use and cost-effective.
Spaced out from monitoring and record controls of Packaging For Pharma Products selection criteria of the same are demarcated in pharmacopoeia and standard documents which are to be a part of daily approval practices. For any process and assortment of packaging material it’s a must to authenticate the procedure requirements and product necessities.
